Methylene Blue
7
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Hemodynamic Effects of Intradermal Methylene Blue During Breast Surgery Under General Anesthesia
Efficacy of Methylene Blue Plus Ropivacaine for Post-Hemorrhoidectomy Pain.
Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery
Efficacy and Safety of Methylene Blue in the Treatment of Severe Septic Shock
Methylene Blue Spray for Identification of Recurrent Laryngeal Nerve and Parathyroid Gland
Laparoscopic Tubal Patency Assessment
BlueCQ Bioavailability